scholarly journals Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective

2011 ◽  
Vol 14 (8) ◽  
pp. 1002-1009 ◽  
Author(s):  
Haesuk Park ◽  
Karen L. Rascati ◽  
Michael S. Keith ◽  
Paul Hodgkins ◽  
Michael Smyth ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Lanthanum Carbonate ◽  
Sevelamer Hydrochloride ◽  
Payer Perspective ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals SP347MORTALITY AND BONE SAFETY OUTCOMES IN PATIENTS WITH END-STAGE RENAL DISEASE RECEIVING LANTHANUM CARBONATE: A LONG-TERM, OBSERVATIONAL STUDY

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii226-iii227
Author(s):  
Alastair Hutchison ◽  
Ravi Thadhani ◽  
Gillian Hall ◽  
Andrew Whelton ◽  
Heinrich Achenbach ◽  
...  
Keyword(s):  
Observational Study ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Lanthanum Carbonate ◽  
Safety Outcomes ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document